We present a computing model based on the DNA strand displacement technique, which performs Bayesian inference. The model will take single-stranded DNA as input data, that represents the presence or absence of a specific molecular signal (evidence). The program logic encodes the prior probability of a disease and the conditional probability of a signal given the disease affecting a set of different DNA complexes and their ratios. When the input and program molecules interact, they release a different pair of single-stranded DNA species whose ratio represents the application of Bayes' law: the conditional probability of the disease given the signal. The models presented in this paper can have the potential to enable the application of probabilistic reasoning in genetic diagnosis in vitro.
Introduction
Since Leonard Adleman's (1994) seminal work on biomolecular computation, different applications have been proposed in the literature. The trend of resolving NPcomplete problems during the early years of the discipline (Lipton 1995) progressively evolved towards nanotechnology and biomedicine-oriented applications, such as genetic diagnosis and drug delivery automata (Benenson et al. 2001 (Benenson et al. , 2003 (Benenson et al. , 2004 Adar et al. 2004 ).
An important research line emerged taking advantage of the DNA strand displacement phenomenon, which can be briefly described as follows: a strand A displaces another strand B from a complex A 0 B, due to the higher affinity between A and A 0 and the greater stability of the duplex AA 0 . We cite only a few contributions to this extensive topic introduced by Yurke et al. (2000) , like for example the design of logic gates (Seelig et al. 2006; Soloveichik et al. 2010; Frezza et al. 2007 ), DNA automata (Takahashi et al. 2006 ) and theoretical models (Cardelli 2009 ).
Interest in molecular logical inference was reawakened by Shapiro's team (Ran et al. 2009 ), who developed an enzyme-driven system able to autonomously perform simple logical deductions with DNA molecules. Since then, our research group has been working on the design of enzyme-free logical inference models that exploit only the DNA strand displacement operation (Rodríguez-Patón et al. 2010 Sainz de Murieta and Rodríguez-Patón 2012a) .
With the exception of research by Benenson's group about stochastic enzymatic reactions (Adar et al. 2004; Benenson et al. 2004) , all the logical models above share a common property: they implement only Boolean logic, and thus their output always represents an absolute truth value (true/false, active/inactive, presence/absence, 1/0, etc.). None of these deterministic models is able to deal with uncertain knowledge. Other enzyme-free models (but not autonomous) have been presented implementing stochastic paradigms (Lim et al. 2010; Zhang and Jang 2005) .
Probabilistic reasoning can be used when we want to consider diagnostic accuracy or test uncertainty in our clinical decisions [i.e. classic systems like Mycin (Shortliffe and Buchanan 1975) ]. With the motivation of designing a model that can process this uncertainty, this article presents a Bayesian biosensor that reasons probabilistically and whose output represents the probability (value between zero and one) of a disease. Such a device can be used to estimate and update the probability of any diagnosis based in the light of new evidence, i.e., based on the presence or absence of a new specific signal (or set of signals). The DNA sensor device would encode two different probabilities as program data: the conditional probability of the signal given the disease (P(signal|disease)) and the prior probability of the disease (P(disease)). Then, when the sensor interacts with an input representing the evidence of a signal (its presence or absence), Bayes' law would be autonomously computed by means of strand displacement cascades, releasing a set of DNA species whose ratio encodes the posterior probability of the disease given the input (P(disease|signal)).
We introduced the foundations of the model elsewhere (Sainz de Murieta and Rodríguez-Patón 2012b). This paper builds on our previous research, presenting an improved design of the conditional probability devices, as well as a kinetic model and the results of an in silico simulation.
The rest of the paper is structured as follows. Section 2 includes a brief review of the main concepts in probability theory and Bayesian inference. Section 3 describes how the model encodes the prior and conditional probabilities, as well as the input evidence. Section 4 shows an example of an inference process that updates the knowledge of a disease applying Bayes' rule and how it is implemented by our model. Section 6 details the scalability and the mapping of the biological evidences as system inputs. Finally, Sect. 7 summarizes the conclusions and future work.
Principles of the model
First we summarize the basic concepts of probability theory and Bayesian inference (Pearl 1988; Russell and Norvig 2002) used throughout the article: Random variable A function whose possible values are numerical outcomes of a random phenomenon. It can take different value domains, including continuous, discrete or Boolean random variables. This paper will focus on Boolean random variables, which have a certain probability of being true or false. For example, the random variable D can be set to represent a given disease, which can be present (true) or absent (false).
Logical proposition A logical formula expressing an assignment between a random variable and one of its potential domain values. Hence, the propositions D = present (also denoted as D 1 ) and D = absent (also denoted as D 0 ) are the possible formulations that can be hypothesized on the random variable D. Generic propositions of a given variable are denoted with the respective lower case letter, for example, P(d) can refer either to P(D 1 ) or P(D 0 ).
Probability function A function P that assigns a probability to each value in the random variable domain (and thus to each potential logical proposition derived from the variable). Building on the above example, the probability of D can be said to be the duple PðdÞ ¼ PðD 1 Þ; PðD 0 Þ h i : The sum of probabilities of all the values of the domain must be equal to one:
When this function is defined without any dependence on other random variables, we call it prior probability. Joint probability The probability of a set of different propositions, a 1 ; . . .; a n ; all happening at the same time is defined by the joint probability function, represented as Pða 1^Á Á Á^a n Þ or Pða 1 ; . . .; a n Þ:
Conditional probability This function can be intuitively seen as the degree of belief in a variable after the observation of other variables related to the first. So the conditional probability of a proposition a given b is the probability of a when b is known to occur. It is commonly denoted as P(a|b). Conditional probability can also be expressed as a function of prior and joint probabilities:
This formula can be derived into the so-called product rule:
Continuing with the above example, when a disease is extensively studied, the probability of a disease d given the signal s is known and expressed as P(d|s). This is also called posterior probability.
Conditional independence Two propositions a and b are conditionally independent when they do not have any dependency relationship. In this case we can rewrite their probabilities as PðajbÞ ¼ PðaÞ; PðbjaÞ ¼ PðbÞ; Pða; bÞ ¼ PðaÞ Á PðbÞ:
Bayes' law Bayes' law can be derived from the conditional probability and the product rule formulations, and is stated as follows:
This rule, together with the property of independence, is key in probabilistic reasoning and is used to establish relationships between probabilities and evidences. It is useful for updating the certainty value of a hypothesis or a diagnosis (prior probability P(d)), in the light of new evidence (P(s)) and the signal likelihood (P(s|d)), in order to output an ''updated'' posterior probability (P(d|s)).
Assuming that we can exhaustively estimate all the probabilities concerning the variable D, we can rewrite the law as:
Since the sum of the probabilities P(D = present|s) and P(D = absent|s) must be equal to one, we can treat a as a normalization factor.
Encoding
Our sensor model aims to implement the product of the probabilities PðsjdÞ Á PðdÞ ¼ Pðd^sÞ shown in Eq. 6. To do this we use single-stranded DNA to encode the prior probabilities (P(d)) and double-stranded complexes to encode conditional probabilities (P(s|d)). Also the input evidence will need a specific DNA encoding. Details follow.
Encoding input evidences
Input evidence is encoded using single-stranded DNA (see Fig. 1 ). A strand S 1 represents the presence of the signal, whereas S 0 represents its absence. As we are dealing with evidences, only one species can be present at a time: either input strands S 1 (meaning the signal is present) or S 0 (meaning the signal is not present). This input will tell the sensor that the prior probability of the disease needs to be updated according to the given evidence. The coloured toeholds at the 3 0 end will allow their interaction with the molecules encoding the conditional probabilities.
If there is a significant concentration of either of the two signals that should not be present, the input would no longer be considered as evidence because the probabilities P i (i = 0, 1) would not be 1 or 0. Thus the results of the computation would be wrong and invalid.
The model assumes toeholds are 6 nucleotides long, where the total length of the strands S i is 30.
Encoding prior probabilities
The prior probability of D is represented as the duple PðdÞ ¼ hPðD 1 Þ; PðD 0 Þi: Our model encodes each value using two different single-stranded species: D 1 representing P(D = present) and D 0 representing P(D = absent). The probability values are implicitly encoded in the ratio of molecules of each species against the total for D. If we denote the number of molecules of each species A i as |A i |, we can express the probability as PðdÞ ¼ jA 1 j jA 1 jþjA 0 j ; Figure 2 shows an example DNA encoding of PðdÞ ¼ 0:5; 0:5 h i: The coloured toeholds at the 5 0 end (also 6 nucleotides long) will be able to interact with the molecules encoding the conditional probabilities. The strands D j are assumed to be 18 nucleotides long.
Encoding conditional probabilities
The conditional probability of s given d needs to encode values for the following propositions:
Clearly, for each proposition strand d interacting with a conditional probability molecule, two different outputs encoding two different joint probabilities can be released: (S = present^d) and (S = absent^d). Therefore, from the four different joint probabilities that could be released from the interaction of the D i species and the conditional probability molecules (representing (S = presentD = present), (S = absent^D = present), (S = present Fig. 1 Encoding input evidence. S 1 represents the presence of the signal; S 0 represents its absence. Only S 1 or S 0 species should be present at the same time iis encoded as the ratio between the number of molecules of each species and the total number of species for d ^D = absent) and (S = absent^D = absent)), the system needs to be able to select only the outputs corresponding to the input evidence:
-If the input evidence is S 1 , the output strands released should encode (S = present^D = present) and (S = present^D = absent). -If the input evidence is S 0 , the output strands released should encode (S = absent^D = present) and (S = absent^D = absent)).
The desired behaviour described above for the conditional probability molecules can be attained using a motif inspired by the AND gate presented by Seelig et al. (2006) . Other motifs implementing such logic could be equally valid, but we have chosen this one due to its simplicity and iteration capability. Figure 3 shows an example of how the strands building the joint probability (depicted as S i^Dj ) are released in the presence of the input evidence S i and D j . Figure 4 shows the detailed motifs of the molecules that encode the conditional probabilities P(s|d). Similarly to the case of prior probabilities, the probability figures are taken as ratios relating to the number of molecules of each motif. It also shows the formula to establish the correspondence between each motif and the conditional probability values they encode.
In order to ensure we are working with probability values, the following restrictions need to be ensured: -Prior probability of the disease:
-Conditional probability of the signal given the disease:
Now we get the confirmation that the signal is present (S = present). What is now the probability of the disease being present given that the signal is present, P(D = present|S = present)? Since we do not know the prior probability of the signal (P(s)), we cannot directly apply the Bayes' law as stated in Eq. 5. We apply the derivation stated in Eq. 6 instead:
In order to find a, we need to calculate P(D = absent|S = present) as well:
Output waste Fig. 3 Encoding conditional probabilities. The panel shows the hybridization flow releasing the joint probability strand S i^Dj when the input evidence S i and D j is present. When S i interacts with the conditional probability device S i |D j , they can bind their free toeholds (D i and *D i ) at an association rate k f . Then they can either unbind with a dissociation rate k r , or initiate a branch migration process that would finish with the input strand fully hybridized to the complex S i |D j , at a rate k b1 . In this stage, the bulge sequestering the toehold *S i is released, which practically disables the possibility of reversing the branch migration, and also enables the binding to the input evidence strand S i . As with the first input, if they do not dissociate (at rate k r ), a second branch migration process would complete the full hybridization of the strand S i to the complex S i |D j , at a rate k b2 . At that point, the output strand S i^Dj and the waste complexes are released. Together with the output strand, a fluorophore is released from its quencher, allowing the measurement of the output. DNA domains named with an asterisk prefix ( 
Since the sum of P(D = present|S = present) and P(D = absent|S = present) is 1 (see Eq. 1), we can derive a = 1.81 and P(D = present|S = present) = 0.73). Following the encoding model described in Sect. 3, we can reproduce the inference process described above with DNA: -The prior probability PðdÞ ¼ h0:5; 0:5i is encoded with two different DNA species, D 1 and D 0 . Each species will count 50 copies (|D 1 | = 50, |D 0 | = 50). -The conditional probabilities are encoded as follows 1 -P(S = absent|D = absent) is encoded with 70 copies of the complex S 0 |D 0 . -P(S = present|D = absent) = 0.3 is encoded with 30 copies of the complex S 1 |D 0 . -P(S = absent|D = present) = 0.2 is encoded with 20 copies of the complex S 0 |D 1 . -P(S = present|D = present) = 0.8 is encoded with 80 copies of the complex S 1 |D 1 .
-The input evidence S = present is encoded with a unique DNA species, S 1 . Its copy number should be considerably greater (e.g. one order of magnitude) than that of the molecules encoding conditional probabilities in order to maximize the release of output strands.
Then the DNA inference process would start by mixing evidence and prior and conditional probabilities all together (see Fig. 5 ):
1. The strands D j interact with the strands S i |D j . Assuming an ideal (perfectly mixed) solution, the number of complexes S i |D j ''activated'' by strands D j would be updated as follows (see Fig. 5 , step 1):
-35 copies of the complex S 0 |D 0 .
-15 copies of the complex S 1 |D 0 .
-10 copies of the complex S 0 |D 1 .
-40 copies of the complex S 1 |D 1 .
2. The input strands S 1 interact with the complexes S 1 |D 0 and S 1 |D 1 , releasing 15 copies of the strand S 1^D0 and 40 copies of the strand S 1^D1 (see Fig. 5 , step 2). 3. The number of copies of each output strand is estimated by the increase of the different fluorescent colours (red for S 1^D0 and green for S 1^D1 , see Fig. 5, step 3) . The only step missing is the calculation of the probability encoded in that output, which is easily done by normalizing both values as follows:
5 Kinetic model and simulation
The DNA devices presented in this paper have been modelled and simulated using Cain, version 1.4. Cain performs stochastic and deterministic simulations of chemical reactions. It offers a wide variety of solvers, including Gillespie's methods and ordinary differential equations (ODE) integration. The reactions in our devices have been modelled according to mass action kinetic laws, and simulated with an ODE solver: Runge-Kutta (CashKarp), with 1,000 frames, 32 bins, histogram multiplicity four and error rate 10 -15 . Fig. 4 Encoding conditional probabilities. The panel shows the four motifs encoding the conditional probabilities P(s|d), together with the formulas that relate their concentrations to the respective probability values
The values for the kinetic constants have been calculated using the following approximation (Zhang and Winfree 2009) . Assuming all the toehold domains in our models are 6 base pairs long (x = 6 in the formulas above), the branch migration triggered by the strands D j traverses 12 nucleotides (x = 12) and the one triggered by the strands D i traverses 24 nucleotides (x = 24), and the average DG o is -10 kcal/mol, the following rates are obtained and used in our simulations: k f ¼ 3:5Ã 10 6 M À1 s À1 ; k r ¼ 5:3 Ã 10 À2 s À1 ;k b 1 = 2.77 s -1 and k b 2 = 0.69 s -1 . The inference process described in Sect. 4 has been modelled according to mass action kinetic laws. The list of equations below 2 translates the interactions between the input evidence strands (S i ), the prior probability strands (D i ) and the conditional probability molecules:
Reactions between species S 0 , D 0 and S 0 |D 0 :
Reactions between species S 0 , D 1 and S 0 |D 1 : Reactions between species S 1 , D 0 and S 1 |D 0 :
Reactions between species S 1 , D 1 and S 1 |D 1 : Figure 6 shows the results of simulating the above equations in Cain with the probability values exemplified in Sect. 4 and the the kinetic constants specified above. Concentrations of each species are given on the scale nanomolar and proportional to the values given in Sect. 4 The output of this simulation clearly matches the analysis performed in Sect. 4.
The complementary case has also been tested: absence of input signal encoded with DNA species S 0 . For details of this example, see Fig. 7 .
Discussion
The DNA biosensor presented here operates as a Bayesian inference device, capable of introducing quantitative information, highlighted by the molecular indicators or signals, into the tests.
Its operation is inspired by the stochasticity of the competing transitions presented in Adar et al. (2004) , also used elsewhere to modulate the ratio between drug and drug suppressor in the output (Benenson et al. 2004 ). This research is also based on transitions competing stochastically, but we use the DNA strand displacement operation to eliminate the dependence on the enzyme FokI. Another aim was to identify how to map the basic concepts of probability theory and Bayesian inference into DNA strand displacement motifs for use as design patterns when implementing Bayesian reasoning with DNA.
An important issue to be addressed is the translation of the biological data from real samples into the input evidence species. When the evidence to be sensed is determined by the presence of a specific nucleic acid strand, the Input signal present -[S1] = 10nM D1 D0 S0^D0.*S0.*D0 S0^D1.*S0.*D1 S1^D0.*S1.*D0 S1^D1.*S1.*D1 S1^D0 S1^D1 Fig. 6 ). Output concentrations of S 0^D0 and S 0^D1 converge around 3.5 and 1 nM, respectively. Applying the normalization step described in Eq. 6 and Sect. 4, we obtain PðS 0 jdÞ ¼ hPðS 0 jD 1 Þ; PðS 0 jD 0 Þi ¼ h strand in question could be directly taken as the input evidence strand S 1 expected by the system. The problem arises if the signal is determined by the absence of a specific nucleic acid strand. How can this be mapped into an input evidence strand S 0 ? One possible solution is to add an additional pre-processing layer, consisting of an extra DNA device as described in Fig. 8 . If there is no input signal from the samples, the device in the pre-processing layer acts like the input strand S 0 ; whereas if an input signal is present, it releases strand S 1 . Another potential solution would be the use of a DNA aptamer (Zhang and Winfree 2008) . Other non-DNA aptamers (Cho et al. 2009 ) could also be used to allow our model to take molecules other than nucleic acids as inputs. For this model to have realistic applications in genetic diagnosis, it needs to deal with more than one signal (s 1 ; . . .; s n ) for the same disease d (superscripts denote the signal number). According to Eq. 6, the following formulation of Bayes' law would need to be solved: -P(d), P(s 1 ) and the evidences S i 1 (i = 0, 1) are encoded as described in Sects. 3 and 4, with subscripts denoting signal absence (0) or presence (1).
-Since the output of the previous steps has the form of species S i 1^D k (i = 0, 1; k = 0, 1), the devices encoding P(s 2 |d) will need to accept the strands S i
1D
k instead of the strands D k . The output of this step will release species S i 1^S j
2^D
k . -This step should be repeated for each P(s x |d) (x ¼ 1; . . .; n) until the last signal is reached.
Conclusions and future work
We have designed a Bayesian DNA expert system for genetic diagnosis. This is a DNA circuit that is able to:
1. Encode diagnostic probabilistic information in DNA strands. 2. Sense DNA/sRNA inputs. 3. Process probabilistic information encoded as DNA strands concentrations. 4. Release an output molecule (a DNA strand encoding a diagnosis with a probability proportional to its concentration). 5. Update the probability of the disease depending on the different DNA inputs detected following Bayes' rule.
The model is completely autonomous, enzyme free and is based on DNA strand displacement techniques. It can be implemented according to the experimentally verified general design derived in Seelig et al. (2006) . According to the properties examined by Chiniforooshan et al. (2011) , the model can be characterized as partly scalable, time responsive and energy efficient.
We think the model presented in this paper has the potential to deliver new quantitative applications of probabilistic genetic diagnosis in vitro. We plan to build, improve and generalize the model in a wet lab to work with all types of Bayesian networks [and not just naïve Bayes approaches (Minsky 1961 Fig. 8 Processing input as absence of DNA strand. If no signal is available among the input samples, the device in the pre-processing layer acts like the input strand S 0 (top-left). However, if an input signal is present (top-right), it releases the strand S 1 (bottom-right), leaving a waste molecule that will not react in the system
